-
A Missed ConversationDespite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
Pushing Progress ForwardNCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”
by Kevin McLaughlin
-
Cancer Care Moves Forward Amid COVID-19Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.
by Kate Yandell
-
Using Leftover Cancer Drugs to Help OthersCancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Medicare Coverage for Next-Generation Sequencing TestsMultigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
Opioid Overdoses in Cancer Patients and SurvivorsThe number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.
by Emma Yasinski
-
Cancer and CreditThe financial burden of a cancer diagnosis can lower a patient's credit score.
by Shelly Rosenfeld
-
First Ladies of Africa Issue Call to Address Cancer CrisisA coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
-
Young Colorectal Cancer Patients Are Often MisdiagnosedA new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
by Bradley Jones
-
Making Clinical Trials More InclusiveBroadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
